-+ 0.00%
-+ 0.00%
-+ 0.00%

NERVGEN PHARMA CORP - NET PROCEEDS TO ADVANCE NVG-291 CLINICAL STUDIES AND FOR GENERAL CORPORATE PURPOSES

Reuters·05/21/2026 20:01:00

Please log in to view news